ArticleBMC cardiovascular disorders2024
Body composition of metabolically unhealthy normal-weight patients with aortic stenosis: a prospective cohort study.
Article in BMC cardiovascular disorders, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundThe aim of this study was to evaluate the prognostic impact of computed tomography (CT)-based body composition parameters in metabolically unhealthy normal-weight patients (MUHNW) with aortic stenosis (AS) undergoing transcatheter aortic valve replacement (TAVR).
methodsThis prospective cohort study involved adults with normal weight scheduled for TAVR. Patients were divided into two groups: metabolically healthy normal-weight (MHNW) and MUHNW. The primary outcome was major adverse cardiovascular events (MACEs), and the secondary outcomes were all-cause mortality and prolonged hospital stay. Logistic regression was used to explore the relationships between variables and outcomes, and Cox regression models were applied to examine the effects of different parameters on patient prognosis. Incremental discriminative improvement (IDI) and the C-index were used to determine the influence of hybrid parameters on the predictive efficiency of the model.
resultsThe cohort study included 182 patients divided into two groups: MHNW metabolically healthy normal-weight (n = 97) and MUHNW (n = 85). Over a median follow-up of 0.8 years, multivariable logistic regression analysis revealed significant associations of the skeletal muscle index (SMind) (HR: 0.50, 95% CI: 0.29 - 0.84, p = 0.01), subcutaneous adipose tissue index (SATind) (HR: 0.63, 95% CI: 0.45 - 0.88, p = 0.01), and visceral adipose tissue index (VATind) (HR: 1.34, 95% CI: 1.10 - 1.63, p < 0.01) with the risk of experiencing MACEs, whereas epicardial adipose tissue (EAT) was not significantly associated with the risk of experiencing MACEs in the multivariable model (HR: 1.10, 95% CI: 0.97 - 1.24, p = 0.14). For the primary outcome, adjusted for significant covariates, the model had an IDI of 0.25 and a C-index of 0.8, with significant associations of SMind (HR: 0.73, 95% CI: 0.62 - 0.87, p < 0.01), SATind (HR: 0.87, 95% CI: 0.78 - 0.97, p = 0.01), and VATind (HR: 1.25, 95% CI: 1.12-1.40, p < 0.01) with the risk of experiencing MACEs. For the secondary outcome, the model had an IDI of 0.36 and a C-index of 0.93, with EAT showing a significant protective effect against all-cause mortality and prolonged hospital stay (HR: 0.97, 95% CI: 0.93 - 0.99; p = 0.04).
conclusionsBody composition parameters, including, VATind, SMind, and SATind, are significant predictors of MACEs in patients undergoing TAVR. Additionally, EAT shows a significant protective effect against all-cause mortality and prolonged hospital stay. These findings highlight the potential importance of comprehensive body composition assessments in the risk stratification and management of AS patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.